688271 联影医疗
已收盘 09-04 15:00:01
资讯
新帖
简况
每周股票复盘：联影医疗（688271）2025年股权激励首期归属130万股市值
证券之星 · 01:21
每周股票复盘：联影医疗（688271）2025年股权激励首期归属130万股市值
联影医疗上半年营收70.5亿：同比增17% 扣非后净利8.3亿同比降14%
雷递网 · 09-04 11:49
联影医疗上半年营收70.5亿：同比增17% 扣非后净利8.3亿同比降14%
8月私募机构调研超6100次 半导体行业关注度居前
证券日报 · 09-04 00:04
8月私募机构调研超6100次 半导体行业关注度居前
外资8月密集调研464家A股上市公司：医药生物热度最高，一家公司被83家外资“光顾”；电子行业38家公司被“盯上”，第三代半导体热度不减
中新经纬 · 09-03 15:48
外资8月密集调研464家A股上市公司：医药生物热度最高，一家公司被83家外资“光顾”；电子行业38家公司被“盯上”，第三代半导体热度不减
股市必读：联影医疗新发布《联影医疗关于召开2026年半年度业绩说明会的公告》
证券之星 · 09-03
股市必读：联影医疗新发布《联影医疗关于召开2026年半年度业绩说明会的公告》
联影医疗（688271）披露2026年半年度权益分派实施后调整回购价格上限公告，9月2日股价下跌1.39%
证券之星 · 09-02
联影医疗（688271）披露2026年半年度权益分派实施后调整回购价格上限公告，9月2日股价下跌1.39%
联影医疗：公司将于9月9日召开2026年半年度业绩说明会
证券日报网 · 09-01
联影医疗：公司将于9月9日召开2026年半年度业绩说明会
联影医疗（688271）披露2025年限制性股票激励计划首次授予部分第一个归属期符合归属条件的公告，8月31日股价下跌1.0%
证券之星 · 08-31
联影医疗（688271）披露2025年限制性股票激励计划首次授予部分第一个归属期符合归属条件的公告，8月31日股价下跌1.0%
股市必读：8月28日联影医疗现1笔大宗交易 机构净买入1.68亿元
证券之星 · 08-31
股市必读：8月28日联影医疗现1笔大宗交易 机构净买入1.68亿元
每周股票复盘：机构净买入联影医疗（688271）1.68亿元
证券之星 · 08-30
每周股票复盘：机构净买入联影医疗（688271）1.68亿元
8月28日联影医疗现1笔大宗交易 机构净买入1.68亿元
证券之星 · 08-28
8月28日联影医疗现1笔大宗交易 机构净买入1.68亿元
联影医疗（688271）披露2026年半年度报告，8月19日股价下跌0.48%
证券之星 · 08-19
联影医疗（688271）披露2026年半年度报告，8月19日股价下跌0.48%
联影医疗：AI赋能医疗器械数量超35款
证券之星 · 08-17
联影医疗：AI赋能医疗器械数量超35款
联影医疗：公司在脑科学领域的长期布局和高端影像设备，正直接服务于脑机接口（BCI）等前沿领域所依赖的基础研究
证券之星 · 08-17
联影医疗：公司在脑科学领域的长期布局和高端影像设备，正直接服务于脑机接口（BCI）等前沿领域所依赖的基础研究
联影医疗新注册《联影医用血管造影X射线机系统Pro版操作软件V2.0》等3个项目的软件著作权
证券之星 · 08-11
联影医疗新注册《联影医用血管造影X射线机系统Pro版操作软件V2.0》等3个项目的软件著作权
每周股票复盘：联影医疗（688271）已回购262万股耗资2.83亿
证券之星 · 08-09
每周股票复盘：联影医疗（688271）已回购262万股耗资2.83亿
联影医疗：已实现超导磁体/梯度、射频/谱仪等全面自主可控
证券之星 · 08-07
联影医疗：已实现超导磁体/梯度、射频/谱仪等全面自主可控
联影医疗：公司磁共振产品线已全面实现零液氦挥发技术
证券之星 · 08-07
联影医疗：公司磁共振产品线已全面实现零液氦挥发技术
联影医疗：上市以来持续实施现金分红
证券之星 · 08-07
联影医疗：上市以来持续实施现金分红
联影医疗：截至2026年3月31日，公司普通股股东总户数为36,273
证券之星 · 08-07
联影医疗：截至2026年3月31日，公司普通股股东总户数为36,273
加载更多
公司概况
公司名称：
上海联影医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2022-08-22
主营业务：
上海联影医疗科技股份有限公司的主营业务是为全球客户提供高性能医学影像设备、放射治疗产品、生命科学仪器。公司的主要产品是磁共振成像系统（MR）、X射线计算机断层扫描系统（CT）、X射线成像系统（XR）、分子影像系统（MI）、超声诊断系统（US）、医用直线加速器系统（RT）、动物MR、动物PET/CT。
发行价格：
109.88
{"stockData":{"symbol":"688271","market":"SH","secType":"STK","nameCN":"联影医疗","latestPrice":108.58,"timestamp":1788505201000,"preClose":105.08,"halted":0,"volume":7322404,"delay":0,"changeRate":0.0333,"floatShares":824000000,"shares":824000000,"eps":2.1456,"marketStatus":"已收盘","change":3.5,"latestTime":"09-04 15:00:01","open":106,"high":109.79,"low":105.1,"amount":796000000,"amplitude":0.0446,"askPrice":108.59,"askSize":2,"bidPrice":108.58,"bidSize":77,"shortable":0,"etf":0,"ttmEps":2.1456,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":5,"adr":0,"adjPreClose":105.08,"symbolType":"stock_kcb","openAndCloseTimeList":[[1788485400000,1788492600000],[1788498000000,1788505200000]],"highLimit":115.59,"lowLimit":94.57,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":824157988,"isCdr":false,"pbRate":4.06,"roa":"--","peRate":50.605891,"roe":"4.12%","epsLYR":2.28,"committee":0.708333,"marketValue":89487000000,"turnoverRate":0.0089,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-09-07。","afterMarket":{"amount":291537.3,"volume":2685,"close":108.58,"buyVolume":0,"sellVolume":3515,"time":1788507237746,"indexStatus":"已收盘 09-04 15:30:00","preClose":105.08},"floatMarketCap":89487000000},"requestUrl":"/m/hq/s/688271","defaultTab":"news","newsList":[{"id":"2665365322","title":"每周股票复盘：联影医疗（688271）2025年股权激励首期归属130万股市值","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365322","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665365322?lang=zh_cn&edition=full","pubTime":"2026-09-06 01:21","pubTimestamp":1788628870,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，联影医疗报收于108.58元，较上周的105.56元上涨2.86%。本周，联影医疗9月4日盘中最高价报109.79元。本周关注点公司公告汇总：2025年限制性股票激励计划首次授予部分第一个归属期归属条件达成，1,315名激励对象可归属1,302,840股。股本股东变化：截至2026年8月31日，公司已累计回购2,624,232股，占总股本的0.32%。业绩披露要点公司2025年度营业收入同比增长33.98%，满足2025年限制性股票激励计划第一个归属期的公司层面业绩考核要求，归属比例为100%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688271"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664914386","title":"联影医疗上半年营收70.5亿：同比增17% 扣非后净利8.3亿同比降14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664914386","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664914386?lang=zh_cn&edition=full","pubTime":"2026-09-04 11:49","pubTimestamp":1788493745,"startTime":"0","endTime":"0","summary":"联影医疗（公司代码：688271）日前发布2026年上半年财报。财报显示，联影医疗2026年上半年营收为70.52亿，较上年同期的60.16亿增长17.22%。","market":"sh","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260904/6392411934128202167923662.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260904/6392411934128202167923662.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n35065/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["688271"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664805616","title":"8月私募机构调研超6100次 半导体行业关注度居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2664805616","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664805616?lang=zh_cn&edition=full","pubTime":"2026-09-04 00:04","pubTimestamp":1788451440,"startTime":"0","endTime":"0","summary":"在上市公司半年报密集披露的8月份，私募机构调研热情显著提升。据私募排排网统计数据，当月共有1072家私募机构参与A股上市公司调研，覆盖599只个股，合计调研次数达6148次，环比增幅高达289.61%。对于8月份私募机构调研力度的明显加大，上海畅力资产管理有限公司董事长宝晓辉对《证券日报》记者表示：“这反映了当前市场环境的现实需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609043864434168.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609043864434168.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1051768304.USD","LU0651947912.USD","LU1255011170.USD","BK0028","BK0225","LU1146622755.USD","IE00BMPRXN33.USD","LU2399975544.HKD","LU1023057109.AUD","300751","LU2213484517.USD","LU2148510915.USD","688271","LU2097828631.EUR","LU2097828557.USD","LU0274383008.USD","LU2294711473.HKD","LU0348825331.USD","LU2348773727.SGD","LU1997245177.USD","LU0261947096.USD","IE0008368742.USD","IE0031814852.USD","300760","BK0171","BK0012","LU2328871848.SGD","LU1655091616.SGD","LU1515016050.SGD","LU0417516902.SGD","LU0327786744.USD","IE00BPRC5H50.USD","HK0000306701.USD","LU2008162690.USD","BK0183","LU0572944931.SGD","LU2097828474.EUR","LU1781817850.SGD","IE00B543WZ88.USD","LU1720050803.USD","LU1734074674.USD","HK0000320264.USD","IE00B031J352.USD","LU1064130708.USD","LU0048597586.USD","LU0455707207.USD","LU2097828805.USD","688600","LU0164865239.USD","IE00B031HY20.USD","BK0196","LU0823426480.USD","LU1979443071.USD","LU1051769294.HKD","LU1580142542.USD","002475","HK0000306685.HKD","SGXZ49509284.SGD","LU0043850808.USD","LU1961090484.USD","LU2476274308.USD","LU2580892789.USD","688037","BK0251","LU0084288322.USD","LU1688375341.USD","BK0072","LU2153592121.USD","LU2177674079.SGD","688050","LU2211815571.USD","688012","LU0650527681.SGD","LU0531971595.HKD","LU0039217434.USD","LU2495084118.USD","SG9999002828.SGD","LU2289578879.USD","LU0594300179.USD","LU0054237671.USD","LU2476274720.SGD","LU1820825898.SGD","688167","LU0823426308.USD","LU0251144936.SGD","LU0359201612.USD","LU2778985437.USD","LU0348827113.USD","IE0005HP3H50.USD","LU0561508036.HKD","LU2348774022.SGD","LU0651946864.USD","LU0259732245.USD","LU1794554557.SGD","LU2488822045.USD","LU2097828714.EUR","LU2460026573.USD","LU0871576103.HKD","LU1934453819.USD","LU0405327494.USD","LU0165289439.USD","BK0188","02475","LU2424517915.HKD","IE00BMPRXR70.SGD","IE00B5MMRT66.SGD","LU0261950983.USD","LU0605514214.HKD","SG9999001226.SGD","LU0502904849.HKD","LU1969619763.USD","IE00B29SXG58.USD","LU0405327148.USD","HK0000320223.HKD","LU2580892862.HKD","LU2242644610.SGD","LU1997245094.SGD","LU2153591404.USD","LU0359202008.SGD","LU1064131003.USD","SGXZ81163826.USD","BK0214","LU0593848301.USD","LU1997244956.HKD","LU0594300419.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664827387","title":"外资8月密集调研464家A股上市公司：医药生物热度最高，一家公司被83家外资“光顾”；电子行业38家公司被“盯上”，第三代半导体热度不减","url":"https://stock-news.laohu8.com/highlight/detail?id=2664827387","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664827387?lang=zh_cn&edition=full","pubTime":"2026-09-03 15:48","pubTimestamp":1788421736,"startTime":"0","endTime":"0","summary":"近期，外资机构对A股公司的调研节奏明显加快。同花顺iFinD数据显示，截至8月31日，外资机构8月单月调研了464家A股上市公司，相较7月211家环比上升120%。外资的调研覆盖面也显著扩大。据中新经纬梳理，医药生物板块跃升为外资8月最关注方向，多家医药公司获外资机构扎堆调研。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609033864030942.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609033864030942.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0405327148.USD","LU2360107325.USD","LU2008162690.USD","LU2153591404.USD","LU1969619763.USD","LU2097828631.EUR","LU0650527681.SGD","BK0072","LU2177674079.SGD","LU0561508036.HKD","BK0070","IE00B5MMRT66.SGD","SG9999002828.SGD","LU2148510915.USD","IE0031814852.USD","01211","LU0651946864.USD","EVS.SI","BK0251","LU1734074674.USD","LU0043850808.USD","LU2213484517.USD","LU0165289439.USD","IE0005HP3H50.USD","LU0531971595.HKD","BK0239","SGXZ81163826.USD","IE00B29SXG58.USD","LU0359202008.SGD","HK0000320264.USD","BK0196","688235","LU2211815571.USD","BK1588","LU0594300419.USD","LU1064131003.USD","LU0084288322.USD","LU2476274720.SGD","LU0039217434.USD","LU1064130708.USD","BK0155","KURE","LU1508157978.USD","LU1997245094.SGD","LU0327786744.USD","06160","LU0651947912.USD","LU1861219969.SGD","LU0261950983.USD","LU2097828474.EUR","LU1861214812.USD","002475","BK0188","BK1500","LU1794554557.SGD","LU2580892862.HKD","LU2778985437.USD","SGXZ49509284.SGD","LU0823426480.USD","LU0259732245.USD","LU0605514214.HKD","LU1146622755.USD","LU1997244956.HKD","LU1934453819.USD","LU1655091616.SGD","LU1580142542.USD","LU1720050803.USD","LU1515016050.SGD","LU0823426308.USD","LU0417516902.SGD","LU2097828714.EUR","LU0054237671.USD","LU0228659784.USD","LU2348773727.SGD","LU1051769294.HKD","LU2153592121.USD","LU0588546209.SGD","LU2348774022.SGD","BK0028","LU1719994722.HKD","LU0405327494.USD","LU2097828805.USD","BK0169","LU0683595622.HKD","LU2476274308.USD","BYDDY","LU1770034418.SGD","LU2424517915.HKD","LU1255011170.USD","LU0251144936.SGD","LU0502904849.HKD","LU1023057109.AUD","002594","BK1583","300760","LU0348827113.USD","IE00BMPRXR70.SGD","BK0183","LU0572944931.SGD","BK0214","LU0274383008.USD","02475","BK0171","LU0633140560.USD","LU2399975544.HKD","LU0307460666.USD","LU1781817850.SGD","LU2289578879.USD","LU0359201612.USD","BK1161","LU1961090484.USD","LU2580892789.USD","LU0633140727.USD","IE00B031HY20.USD","LU2328871848.SGD","LU0594300179.USD","IE00BMPRXN33.USD","LU0164865239.USD","LU1251922891.USD","BK0014","IE0008368742.USD","LU2242644610.SGD","IE00BPRC5H50.USD","LU0828237510.HKD","LU2294711473.HKD","688271","LU0048597586.USD","LU1688375341.USD","LU1820825898.SGD","LU0593848301.USD","LU2488822045.USD","LU0455707207.USD","LU2495084118.USD","LU1979443071.USD","HK0000306701.USD","LU1303224171.USD","LU1997245177.USD","IE00B031J352.USD","IE00B543WZ88.USD","LU0348825331.USD","LU2663582299.SGD","ONC","HK0000320223.HKD","HK0000306685.HKD","LU0261947096.USD","LU0871576103.HKD","LU2097828557.USD","LU1051768304.USD","BK0012","BK0264","688012","300832"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664843738","title":"股市必读：联影医疗新发布《联影医疗关于召开2026年半年度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843738","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664843738?lang=zh_cn&edition=full","pubTime":"2026-09-03 01:19","pubTimestamp":1788369548,"startTime":"0","endTime":"0","summary":"公司公告汇总：联影医疗将于9月9日召开2026年半年度业绩说明会，董事长张强、总经理GUOSHENG TAN等高管将出席。投资者可于9月2日至9月8日16:00前提交问题。联影医疗关于2026年半年度权益分派实施后调整回购价格上限的公告因实施每股0.13元（含税）现金分红，回购价格上限由139.82元/股调整为139.69元/股，调整起始日为2026年9月9日。调整后预计回购股份数量为214.76万股至429.52万股，占总股本的0.26%-0.52%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300001556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688271"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664817740","title":"联影医疗（688271）披露2026年半年度权益分派实施后调整回购价格上限公告，9月2日股价下跌1.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664817740","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664817740?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:27","pubTimestamp":1788359234,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，联影医疗报收于104.23元，较前一交易日下跌1.39%，最新总市值为859.02亿元。该股当日开盘105.7元，最高106.3元，最低103.81元，成交额达3.76亿元，换手率为0.44%。近日，联影医疗发布《关于2026年半年度权益分派实施后调整回购价格上限的公告》。公告显示，公司因实施2026年半年度权益分派，每股派发现金红利0.13元（含税），根据回购方案相关规定，对回购股份价格上限进行调整。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200042995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688271","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664857398","title":"联影医疗：公司将于9月9日召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2664857398","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664857398?lang=zh_cn&edition=full","pubTime":"2026-09-01 21:31","pubTimestamp":1788269460,"startTime":"0","endTime":"0","summary":"证券日报网讯9月1日，联影医疗发布公告称，公司计划于2026年9月9日16：00-17：00举行2026年半年度业绩说明会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-01/doc-iniqitrq4830458.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-01/doc-iniqitrq4830458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688271","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663531001","title":"联影医疗（688271）披露2025年限制性股票激励计划首次授予部分第一个归属期符合归属条件的公告，8月31日股价下跌1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663531001","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663531001?lang=zh_cn&edition=full","pubTime":"2026-08-31 22:27","pubTimestamp":1788186441,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，联影医疗报收于104.5元，较前一交易日下跌1.0%，最新总市值为861.25亿元。该股当日开盘105.58元，最高105.62元，最低103.05元，成交额达4.06亿元，换手率为0.47%。公告显示，公司2025年限制性股票激励计划首次授予部分第一个归属期归属条件已成就。公司层面业绩考核达标，2025年度营业收入同比增长33.98%，满足第一个归属期业绩要求，公司层面归属比例为100%。本次归属不涉及董事，有1名高级管理人员参与。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100037443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688271"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663047836","title":"股市必读：8月28日联影医疗现1笔大宗交易 机构净买入1.68亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663047836","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663047836?lang=zh_cn&edition=full","pubTime":"2026-08-31 04:02","pubTimestamp":1788120138,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，联影医疗报收于105.56元，上涨0.27%，换手率0.31%，成交量2.53万手，成交额2.66亿元。交易信息汇总资金流向8月28日主力资金净流出1593.26万元，占总成交额5.98%；游资资金净流入473.66万元，占总成交额1.78%；散户资金净流入1119.6万元，占总成交额4.2%。大宗交易8月28日联影医疗现1笔大宗交易，机构净买入1.68亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100001102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688271"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663201045","title":"每周股票复盘：机构净买入联影医疗（688271）1.68亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663201045","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663201045?lang=zh_cn&edition=full","pubTime":"2026-08-30 03:31","pubTimestamp":1788031870,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，联影医疗（688271）报收于105.56元，较上周的106.0元下跌0.42%。本周，联影医疗8月26日盘中最高价报107.55元。8月24日盘中最低价报104.59元。联影医疗当前最新总市值869.98亿元，在医疗器械板块市值排名2/129，在两市A股市值排名231/5211。本周关注点来自交易信息汇总：8月28日联影医疗现1笔大宗交易，机构净买入1.68亿元交易信息汇总8月28日联影医疗现1笔大宗交易，机构净买入1.68亿元以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688271","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662069945","title":"8月28日联影医疗现1笔大宗交易 机构净买入1.68亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662069945","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662069945?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:01","pubTimestamp":1787911300,"startTime":"0","endTime":"0","summary":"证券之星消息，8月28日联影医疗发生大宗交易，交易数据如下：大宗交易成交价格105.42元，相对当日收盘价折价0.13%，成交159.6万股，成交金额16825万元，买方营业部为机构专用，卖方营业部为中国国际金融股份有限公司上海分公司。近三个月该股共发生2笔大宗交易，合计成交3.32万手，折价成交2笔。截至2026年8月28日收盘，联影医疗报收于105.56元，上涨0.27%，换手率0.31%，成交量2.53万手，成交额2.66亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800042152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688271"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660429336","title":"联影医疗（688271）披露2026年半年度报告，8月19日股价下跌0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660429336","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660429336?lang=zh_cn&edition=full","pubTime":"2026-08-19 22:07","pubTimestamp":1787148436,"startTime":"0","endTime":"0","summary":"截至2026年8月19日收盘，联影医疗报收于108.65元，较前一交易日下跌0.48%，最新总市值为895.45亿元。近日，联影医疗发布2026年半年度报告。本报告期实现营业收入7,051,579,098.09元，同比增长17.22%；利润总额为1,033,041,160.87元，同比下降3.72%；归属于上市公司股东的净利润为896,995,952.14元，同比下降10.12%；归属于上市公司股东的扣除非经常性损益的净利润为826,729,990.53元，同比下降14.38%。研发投入占营业收入的比例为19.61%，较上年同期增加0.66个百分点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900042912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688271"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660488582","title":"联影医疗：AI赋能医疗器械数量超35款","url":"https://stock-news.laohu8.com/highlight/detail?id=2660488582","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660488582?lang=zh_cn&edition=full","pubTime":"2026-08-17 15:33","pubTimestamp":1786952030,"startTime":"0","endTime":"0","summary":"从行业发展趋势来看，AI已从底层技术创新迈向深度临床赋能。同时，AI重建技术的适用范围从常规FDG拓展至更多类型核药成像，赋能多病种的精准诊断。此外，根据美国FDA公开发布的人工智能赋能医疗器械清单，放射影像是全球AI赋能医疗器械获批最为集中的领域。截至目前，联影医疗获FDA许可的AI赋能医疗器械数量超过35款，在同业中处于前列。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700014234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688271","BK1574","BK1583","159883","BK0251","09996","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660885684","title":"联影医疗：公司在脑科学领域的长期布局和高端影像设备，正直接服务于脑机接口（BCI）等前沿领域所依赖的基础研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2660885684","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660885684?lang=zh_cn&edition=full","pubTime":"2026-08-17 15:33","pubTimestamp":1786952029,"startTime":"0","endTime":"0","summary":"公司在脑科学领域的长期布局和高端影像设备，正直接服务于脑机接口等前沿领域所依赖的基础研究。2020年9月，中国人脑图谱研究科创平台正式发布，该平台的落地对于建立更高质量、更精准的脑图谱体系、推动脑科学研究新突破具有重要意义。项目周期为三年，由联影医疗联合清华大学、天津大学、中国科学院深圳先进技术研究院、中山大学肿瘤防治中心、天津市环湖医院等产学研医多方力量，共同开展多个子课题研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700014231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688271","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658955669","title":"联影医疗新注册《联影医用血管造影X射线机系统Pro版操作软件V2.0》等3个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2658955669","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658955669?lang=zh_cn&edition=full","pubTime":"2026-08-11 02:22","pubTimestamp":1786386136,"startTime":"0","endTime":"0","summary":"证券之星消息，近日联影医疗新注册了3个项目的软件著作权，包括《联影医用血管造影X射线机系统Pro版操作软件V2.0》、《联影医用血管造影X射线机系统Basic版操作软件V2.0》、《联影医用血管造影X射线机系统操作软件V2.0》等。今年以来联影医疗新注册软件著作权12个，较去年同期减少了25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100001899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","159180","688271"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919673","title":"每周股票复盘：联影医疗（688271）已回购262万股耗资2.83亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919673","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658919673?lang=zh_cn&edition=full","pubTime":"2026-08-09 01:29","pubTimestamp":1786210149,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，联影医疗报收于112.55元，较上周的115.52元下跌2.57%。本周，联影医疗8月3日盘中最高价报117.17元。截至2026年7月31日，公司已累计回购2,624,232股，占总股本的0.32%；回购最高价为111.50元/股，最低价为99.21元/股，已支付总金额283,309,111.95元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688271"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657613495","title":"联影医疗：已实现超导磁体/梯度、射频/谱仪等全面自主可控","url":"https://stock-news.laohu8.com/highlight/detail?id=2657613495","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657613495?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:03","pubTimestamp":1786089788,"startTime":"0","endTime":"0","summary":"证券之星消息，联影医疗08月07日在投资者关系平台上答复投资者关心的问题。公司自设立以来，围绕\"自主创新强化竞争优势、全球引领创造临床价值\"的创新策略，联影医疗始终以自主创新为核心驱动力，持续加大研发投入，在关键技术领域实现多项重大突破，逐步建立起涵盖磁体、射频和功率放大器、球管、高压发生器及探测器等核心零部件在内的完整自研体系。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700024641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688271","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657361394","title":"联影医疗：公司磁共振产品线已全面实现零液氦挥发技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2657361394","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657361394?lang=zh_cn&edition=full","pubTime":"2026-08-07 15:57","pubTimestamp":1786089430,"startTime":"0","endTime":"0","summary":"液氦价格变化对公司净利润的直接影响相对可控。目前，公司磁共振产品线已全面实现零液氦挥发技术，大幅降低设备全生命周期的维护成本。针对行业前瞻性的无液氦技术，公司已完成无液氦磁体系统样机开发，并持续进行迭代优化。与此同时，公司通过多维度措施积极应对液氦价格波动。该模式目前已覆盖全球近70个国家和地区，累计安全交付超500台核磁共振系统，2024年度总计节约液氦近700,000升，截至2025年末已累计实现物流降本效益超3.7亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700023980.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688271"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657289618","title":"联影医疗：上市以来持续实施现金分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2657289618","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657289618?lang=zh_cn&edition=full","pubTime":"2026-08-07 15:37","pubTimestamp":1786088238,"startTime":"0","endTime":"0","summary":"证券之星消息，联影医疗08月07日在投资者关系平台上答复投资者关心的问题。公司每年的回购 是否也考虑给中小股东现金分红。公司高度重视全体股东的合法权益，并综合考虑经营发展、资金安排及股东回报等因素，依法依规制定利润分配和股份回购方案。上市以来，公司持续实施现金分红，积极与投资者共享经营发展成果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700021388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688271","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657618251","title":"联影医疗：截至2026年3月31日，公司普通股股东总户数为36,273","url":"https://stock-news.laohu8.com/highlight/detail?id=2657618251","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657618251?lang=zh_cn&edition=full","pubTime":"2026-08-07 15:37","pubTimestamp":1786088237,"startTime":"0","endTime":"0","summary":"证券之星消息，联影医疗(688271)08月07日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，贵公司截至目前最新的股东人数是多少？谢谢！联影医疗回复：尊敬的投资者，您好！根据上市公司信息披露相关规定，公司会在定期报告中披露截止报告期末的股东户数。截至2026年3月31日，公司普通股股东总户数为36,273。感谢您对公司的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。相关 ETF责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700021383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688271"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788646012740,"stockEarnings":[{"period":"1week","weight":0.0286},{"period":"1month","weight":-0.0385},{"period":"3month","weight":-0.0374},{"period":"6month","weight":-0.1217},{"period":"1year","weight":-0.2291},{"period":"ytd","weight":-0.1334}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0133},{"period":"3month","weight":-0.0242},{"period":"6month","weight":-0.0471},{"period":"1year","weight":0.0436},{"period":"ytd","weight":-0.0098}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海联影医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"40380人(较上一季度增加11.32%)","perCapita":"20410股","listingDate":"2022-08-22","address":"上海市嘉定区城北路2258号","registeredCapital":"82415万元","survey":" 上海联影医疗科技股份有限公司的主营业务是为全球客户提供高性能医学影像设备、放射治疗产品、生命科学仪器。公司的主要产品是磁共振成像系统（MR）、X射线计算机断层扫描系统（CT）、X射线成像系统（XR）、分子影像系统（MI）、超声诊断系统（US）、医用直线加速器系统（RT）、动物MR、动物PET/CT。","listedPrice":109.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"联影医疗(688271)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供联影医疗(688271)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"联影医疗,688271,联影医疗股票,联影医疗股票老虎,联影医疗股票老虎国际,联影医疗行情,联影医疗股票行情,联影医疗股价,联影医疗股市,联影医疗股票价格,联影医疗股票交易,联影医疗股票购买,联影医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"联影医疗(688271)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供联影医疗(688271)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}